We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Acupuncture Relieves Postoperative Effects of Anesthesia

By HospiMedica staff writers
Posted on 02 Nov 2001
Early results of an ongoing study of breast surgery patients show that acupuncture is as effective if not better in relieving postoperative nausea and vomiting as the antiemetic ondansetron and has fewer side effects. More...
The study is being conducted by researchers from Duke University Medical Center (Durham, NC, USA).

Up to 70% of women undergoing major breast cancer surgery experience significant postoperative nausea and vomiting, according to the researchers. The study enrolled 40 women who were undergoing major breast surgery requiring general anesthesia. The procedures lasted between two to four hours, and most women were discharged after spending the night in the hospital. The women were divided into three groups. One group received acupuncture before surgery, one received ondansetron prior to surgery, and the third group received neither. For the acupuncture patients, the researchers used an electroacupuncture device, which delivers a small electrical pulse through the skin.

Two hours after surgery, 23% of the acupuncture patients reported nausea, compared to 36% for the drug and 69% for placebo. After 24 hours, 38% of acupuncture patients reported nausea, compared to 57% for the drug and 61% for placebo. Two hours after surgery, 7% of acupuncture patients reported vomiting, compared to 7% who received ondansetron and 23% who received neither. After 24 hours, 23% of acupuncture patients reported vomiting, compared to 28% for the drug and 46% for placebo.

"We were most surprised by the level of pain reported by women, with 31% of acupuncture patients reporting moderate to severe pain two hours after surgery, compared to 64% for ondansetron and 77% for placebo,” said Dr. Tong Joo Gan, a Duke anesthesiologist and lead investigator. Dr. Gan presented the study during the annual scientific sessions of the American Society of Anesthesiologists in New Orleans (LA, USA).




Related Links:
Duke University Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.